Research
Stifel Initiates Lyell Immunopharma at Buy With $36 Price Target
Lyell Immunopharma (LYEL) has an average rating of overweight and mean price target of $37.88, according to analysts polled by FactSet.
$LYEL
$LYEL
4 stories mentioning LYELUpdated 46d ago
Every FINWIRES story that references LYEL, newest first.
What are analysts saying about LYEL?
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
What's the latest news on LYEL?
Research
B. Riley Initiates Lyell Immunopharma at Buy With $44 Price Target
Lyell Immunopharma (LYEL) has an average rating of overweight and mean price target of $38.14, according to analysts polled by FactSet.
$LYEL
Research
Baird Initiates Lyell Immunopharma at Outperform With $49 Price Target
Lyell Immunopharma (LYEL) has an average rating of buy and mean price target of $42.20, according to analysts polled by FactSet.
$LYEL
Research
Needham & Co Initiates Coverage on Lyell Immunopharma With Strong Buy Rating, $44 Price Target
Lyell Immunopharma (LYEL) has an average rating of Buy and mean price target of $40.50, according to analysts polled by FactSet.
$LYEL
